Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
A consensus seems to exist that people with a 30% risk
of a coronary event in 10 years should be treated, since the benefits greatly outweigh the harms. But in their discussion of the policy issues raised by the use of absolute risk guidelines Robson et al point
out that if the threshold is reduced to a 15% risk a quarter of the
population aged 35-69 might be treated (p 702). They argue that
concerns about cost of treatment at lower thresholds should not obscure
the need to treat the 10% of the population with cardiovascular
disease or a 30% risk. They call for a national programme to implement
intervention for these people while policy options for those below a
30% risk are reviewed. The authors ask whether assessing this risk
should be a routine addition to screening for smoking and raised blood
pressure. It may not be worth measuring lipids to estimate risk as they
contribute little in addition to age, sex, smoking, and blood pressure,
but the cost effectiveness of this and other strategies remain to be determined.